Literature DB >> 7734850

Alterations of O-glycan biosynthesis in human colon cancer tissues.

J M Yang1, J C Byrd, B B Siddiki, Y S Chung, M Okuno, M Sowa, Y S Kim, K L Matta, I Brockhausen.   

Abstract

Human colon cancer is associated with antigenic and structural changes in mucin-type carbohydrate chains (O-glycans). To elucidate the control of the biosynthesis of these O-glycans is colon cancer, we have studied glycosyltransferase and sulphotransferase activities involved in the assembly of elongated O-glycan structures. We analysed homogenates prepared from cancer tissue, adjacent normal and distal normal tissue from 20 patients. Several transferase activities showed pronounced changes in cancer tissue. The changes correlate with previous findings of a loss of O-glycans in cancer mucins, but did not always correlate with levels of Tn, sialyl-Tn, T and Lex antigens in homogenates or with the differentiation status and Duke's stages of the cancer tissue or the patient's blood type, sex and age. UDP-GlcNAc: Gal NAc-R beta 3-N-acetylglucosaminyltransferase (where GlcNAc is N-acetyl-D-glucosamine and GalNAc is N-acetyl-D-galactosamine) synthesizing O-glycan core 3, GlcNAc beta 1-3GalNAc-, CMP-sialic acid: GalNAc-peptide alpha 6-sialyltransferase synthesizing the sialyl-Tn antigen and sulphotransferase activities towards O-glycan core 1, Gal beta 1-3GalNAc-, were found to be decreased in cancer. UDP-GlcNAc: Gal beta 1-3GalNAc beta 6-N-acetylglucosaminyltransferase was also decreased in cancer concomitant with a loss of the ability to synthesize the I antigen and core 4, GlcNAc beta 1-6(GlcNAc beta 1-3) GalNAc-, CMP-sialic acid: Gal beta 1-3GalNAc-R alpha 3-sialyltransferase and GDP-fucose: Gal beta-R alpha 2-fucosyltransferase, synthesizing the blood group H determinant, were found to be 4- and 3- to 8-fold increased, respectively, in cancer compared to normal tissue. The data suggest that the biosynthesis of antigens and mucin-bound O-glycan structures in colon cancer is subject to complex control mechanisms.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7734850     DOI: 10.1093/glycob/4.6.873

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  33 in total

1.  Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium.

Authors:  Y J Kim; L Borsig; H L Han; N M Varki; A Varki
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

Review 2.  Sialyltransferases in cancer.

Authors:  F Dall'Olio; M Chiricolo
Journal:  Glycoconj J       Date:  2001 Nov-Dec       Impact factor: 2.916

Review 3.  Intestinal candyfloss.

Authors:  Inka Brockhausen
Journal:  Biochem J       Date:  2004-12-01       Impact factor: 3.857

Review 4.  Nucleic acid aptamers: clinical applications and promising new horizons.

Authors:  X Ni; M Castanares; A Mukherjee; S E Lupold
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

Review 5.  Simple sugars to complex disease--mucin-type O-glycans in cancer.

Authors:  Matthew R Kudelka; Tongzhong Ju; Jamie Heimburg-Molinaro; Richard D Cummings
Journal:  Adv Cancer Res       Date:  2015-02-07       Impact factor: 6.242

6.  Protein glycosylation in cancer biology: an overview.

Authors:  F Dall'olio
Journal:  Clin Mol Pathol       Date:  1996-06

7.  Altered colonic glycoprotein expression in unaffected monozygotic twins of inflammatory bowel disease patients.

Authors:  K Bodger; J Halfvarson; A R Dodson; F Campbell; S Wilson; R Lee; E Lindberg; G Järnerot; C Tysk; J M Rhodes
Journal:  Gut       Date:  2006-02-04       Impact factor: 23.059

8.  Fucosyltransferase III and sialyl-Le(x) expression correlate in cultured colon carcinoma cells but not in colon carcinoma tissue.

Authors:  C Hanski; E Klussmann; J Wang; C Böhm; D Ogorek; M L Hanski; S Krüger-Krasagakes; J Eberle; A Schmitt-Gräff; E O Riecken
Journal:  Glycoconj J       Date:  1996-10       Impact factor: 2.916

9.  Core 3 synthase is down-regulated in colon carcinoma and profoundly suppresses the metastatic potential of carcinoma cells.

Authors:  Toshie Iwai; Takashi Kudo; Risa Kawamoto; Tomomi Kubota; Akira Togayachi; Toru Hiruma; Tomoko Okada; Toru Kawamoto; Kyoei Morozumi; Hisashi Narimatsu
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-08       Impact factor: 11.205

10.  Glycosylation potential of human prostate cancer cell lines.

Authors:  Yin Gao; Vishwanath B Chachadi; Pi-Wan Cheng; Inka Brockhausen
Journal:  Glycoconj J       Date:  2012-07-28       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.